支架设计对颈动脉支架置入术临床与影像学结局影响的荟萃分析
该系统评价与荟萃分析检索了MEDLINE、Embase和Cochrane数据库,纳入2项随机对照试验和66项队列研究(共46,728例手术),评估支架设计对颈动脉支架置入术临床和影像学结局的影响。
要点
- 开环与闭环/混合支架的短期和中期临床主要不良事件率相似。
- 不同支架设计在再狭窄、支架断裂或术中血流动力学抑制方面无差异。
核心结论
- 支架设计并非颈动脉支架置入术患者短期或中期临床主要不良事件率的关联因素。
- 开环与闭环支架的划分可能掩盖了单个支架疗效的真实差异。
- 开环支架置入与术后MR-DWI检测到的亚临床新发缺血病灶数量显著高于闭环支架相关。
研究设计与样本
- 系统检索MEDLINE、Embase和Cochrane数据库(2018年5月),纳入报告不同支架设计用于治疗颈动脉狭窄的临床短期和中期主要不良事件或影像学不良事件的文献。
- 共纳入2项随机对照试验和66项队列研究,包含46,728例手术。
- 采用随机效应模型计算合并总体效应量,并进行Meta回归分析特定支架对主要不良事件率的影响。
主要发现
- 短期临床主要不良事件率:开环支架与闭环或混合支架相似。
- 中期临床主要不良事件率:开环与闭环支架相似。
关键数值与推荐
- 短期主要不良事件(任何卒中或死亡)率:开环 vs 闭环/混合支架相似。
- 再狭窄、支架断裂或术中血流动力学抑制发生率在不同支架设计间无差异。
临床怎么用
- 选择颈动脉支架时,开环与闭环设计在短期和中期临床主要不良事件方面无显著差异。
- 开环支架与更多亚临床术后新发缺血病灶相关,临床决策时需结合患者个体情况权衡。
- 特定支架(如Acculink vs Wallstent、Precise vs Xact)的短期主要不良事件风险差异需进一步验证。
局限性
- 需要个体患者数据的荟萃分析,纳入未来前瞻性同质研究设计,以充分校正已知危险因素。
- 需针对特定亚组提供关于颈动脉支架设计的明确结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Procedural characteristics, including stent design, may influence the outcome of carotid artery stenting (CAS). A thorough comparison of the effect of stent design on outcome of CAS is thus warranted to allow for optimal evidence-based clinical decision making. This study sought to evaluate the effect of stent design on clinical and radiologic outcomes of CAS. METHODS: A systematic search was conducted in MEDLINE, Embase, and Cochrane databases in May 2018. Included were articles reporting on the occurrence of clinical short- and intermediate-term major adverse events (MAEs; any stroke or death) or radiologic adverse events (new ischemic lesions on postprocedural magnetic resonance diffusion-weighted imaging [MR-DWI], restenosis, or stent fracture) in different stent designs used to treat carotid artery stenosis. Random effects models were used to calculate combined overall effect sizes. Metaregression was performed to identify the effect of specific stents on MAE rates. RESULTS: From 2654 unique identified articles, two randomized, controlled trials and 66 cohort studies were eligible for analysis (including 46,728 procedures). Short-term clinical MAE rates were similar for patients treated with open cell vs closed cell or hybrid stents. Use of an Acculink stent was associated with a higher risk of short-term MAE compared with a Wallstent (risk ratio [RR], 1.51; P = .03), as was true for use of Precise stent vs Xact stent (RR, 1.55; P < .001). Intermediate-term clinical MAE rates were similar for open vs closed cell stents. Use of open cell stents predisposed to a 25% higher chance (RR, 1.25; P = .03) of developing postprocedural new ischemic lesions on MR-DWI. No differences were observed in the incidence of restenosis, stent fracture, or intraprocedural hemodynamic depression with respect to different stent design. CONCLUSIONS: Stent design is not associated with short- or intermediate-term clinical MAE rates in patients undergoing CAS. Furthermore, the division in open and closed cell stent design might conceal true differences in single stent efficacy. Nevertheless, open cell stenting resulted in a significantly higher number of subclinical postprocedural new ischemic lesions detected on MR-DWI compared with closed cell stenting. An individualized patient data meta-analysis, including future studies with prospective homogenous study design, is required to adequately correct for known risk factors and to provide definite conclusions with respect to carotid stent design for specific subgroups.
引用
- de Vries EE, Meershoek AJA, Vonken EJ, et al. A meta-analysis of the effect of stent design on clinical and radiologic outcomes of carotid artery stenting. J Vasc Surg. 2019. PMID: 31159989. doi:10.1016/j.jvs.2018.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。